(Q43647917)

English

Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rik L. de Swart

object named as

Rik L de Swart

8

0 references

5

object named as

Bernard Moss

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Geert van Amerongen

4

object named as

Geert van Amerongen

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

3

object named as

Selma Yüksel

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

object named as

Linda S Wyatt

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hubert G.M. Niesters

6

object named as

Hubert G M Niesters

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Leon de Waal

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

923-926

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Respiratory syncytial virus: reverse genetics and vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.10.010

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43647917&oldid=2102307053"